AFMD - アフィメド （Affimed N.V.）

Affimed N.V. (NASDAQ:NASDAQ:AFMD) Q1 2023 Earnings Conference Call May 23, 2023 8:30 AM ETCompany ParticipantsAlex Fudukidis - Director of Investor RelationsAdi Hoess - Chief Executive…

Shares of biopharmaceutical company Affimed (NASDAQ:AFMD) are on the rise today after the U.S. Food and Drug Administration (FDA) gave a go-ahead t…

Companies Reporting Before The Bell • ATRenew (NYSE: RERE ) is estimated to report quarterly earnings at $0.03 per share on revenue of $405.22 million. • Endava (NYSE: DAVA ) is expected to report quarterly earnings at $0.66 per share on revenue of $251.01 million. • Dick''s Sporting Goods (NYSE: DKS ) is estimated to report quarterly earnings at $3.18 per share on revenue of $2.80 billion. • Lowe''s Companies (NYSE: LOW ) is estimated to report quarterly earnings at $3.44 per share on revenue of $21.60 billion. • T2 Biosystems (NASDAQ: TTOO ) is expected to report quarterly loss at $1.20 per share on revenue of $2.33 million. • Kingsoft Cloud Hldgs (NASDAQ: KC ) is projected to report quarterly loss at $0.23 per share on revenue of $282.80 million. • Zepp Health (NYSE: ZEPP ) is projected to report quarterly loss at $0.02 per share on revenue of $122.93 million. • Affimed (NASDAQ: AFMD ) is estimated to report quarterly loss at $0.21 per share on revenue of $5.69 million. • Vipshop Holdings (NYSE: VIPS ) is likely to report quarterly earnings at $0.37 per share on revenue of $3.72 billion. • Navios Maritime Partners (NYSE: NMM ) is likely to report quarterly earnings at $3.16 per share on revenue of $312.00 million. • …

HEIDELBERG, Germany (AP) — HEIDELBERG, Germany (AP) — Affimed N.V. (AFMD) on Tuesday reported a loss of $34.3 million in…

AFM13 combination with AB-101 NK cells: Received IND clearance from the FDA for a phase 2 clinical trial investigating the combination therapy in relapsed/refractory (r/r) classical Hodgkin Lymphom…

https://www.investing.com/news/pro/affimed-therapeutics-receives-investment-bank-analyst-rating-update-432SI-3040892

https://www.investing.com/news/pro/affimed-therapeutics-pt-lowered-to-1-at-stifel-432SI-3038997

Affimed N.V. (NASDAQ:NASDAQ:AFMD) Q4 2022 Earnings Conference Call March 23, 2023 8:30 AM ETCompany ParticipantsAlex Fudukidis - Director of Investor RelationsAdi Hoess - Chief Executive…

Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ: CGTX ) is likely to report earnings for its fourth quarter. • Affimed (NASDAQ: AFMD ) is expected to report quarterly loss at $0.21 per share on revenue of $7.38 million. • Energy Focus (NASDAQ: EFOI ) is estimated to report quarterly loss at $0.26 per share on revenue of $4.20 million. • AstroNova (NASDAQ: ALOT ) is projected to report earnings for its fourth quarter. • Hywin Holdings (NASDAQ: HYW ) is expected to report earnings for its first quarter. • Perma-Fix Envirn Servs (NASDAQ: PESI ) is likely to report earnings for its fourth quarter. • Mogo (NASDAQ: MOGO ) is likely to report quarterly loss at $0.09 per share on revenue of $16.20 million. • Exscientia (NASDAQ: EXAI ) is projected to report quarterly loss at $0.32 per share on revenue of $8.26 million. • Movado Group (NYSE: MOV ) is expected to report quarterly earnings at $0.86 per share on revenue of $184.40 million. • REX American Resources (NYSE: REX ) is expected to report quarterly earnings at $0.25 per share on revenue of $210.15 million. • Altisource Asset Mgmt (AMEX: AAMC ) is projected to report earnings for its fourth quarter. • Priority Tech Holdings (NASDAQ: PRTH ) is projected to report quarterly loss at $0.07 per share on revenue of $165.25 million. • BRP (NASDAQ: DOOO ) is likely to report quarterly earnings at $2.76 per share on revenue of $2.19 billion. • Direxion Daily CSI China Internet Index Bull 2X Shares (NYSE: CWEB ) is projected to report quarterly loss at $0.05 per share on revenue of $33.70 million. • Gambling.com Gr (NASDAQ: GAMB ) is expected to report quarterly earnings at $0.07 per share on revenue of $18.27 million. • General Mills (NYSE: GIS ) is projected to report quarterly earnings at $0.91 per share on revenue of $4.94 billion. • Darden Restaurants (NYSE: DRI ) is estimated to report quarterly earnings at $2.21 per share on …

In Wednesday’s session, Affimed N.V. (NASDAQ:AFMD) marked $0.97 per share, down from $0.99 in the previous session. While Affimed N.V. has underperformed by -2.22%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, AFMD fell by -77.09%, with highs and lows ranging from $5.10 to $0.98, whereas […]

In Wednesday’s session, Affimed N.V. (NASDAQ:AFMD) marked $0.97 per share, down from $0.99 in the previous session. While Affimed N.V. has underperformed by -2.22%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, AFMD fell by -77.09%, with highs and lows ranging from $5.10 to $0.98, whereas […]

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Alluring stocks: Affimed N.V. (NASDAQ:AFMD -2.22%), Ambrx Biopharma Inc. (NYSE:AMAM 0.22%) appeared first on Stocks Equity .

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Current Investor’s Watch List: Bit Digital, Inc. (NASDAQ:BTBT), Affimed N.V. (NASDAQ:AFMD) appeared first on Stocks Equity .

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Spellbinding stocks: Affimed N.V. (NASDAQ:AFMD -3.04%), Avino Silver & Gold Mines Ltd. (AMEX:ASM -3.42%) appeared first on Stocks Equity .

In the latest trading session, 0.56 million Affimed N.V. (NASDAQ:AFMD) shares changed hands as the company’s beta touched 2.53. With the company’s most recent per share price at $1.00 changed hands at -$0.02 or -1.47% at last look, the market valuation stands at $145.90M. AFMD’s current price is a discount, trading about -410.0% off its … Is Affimed N.V. (NASDAQ: AFMD) Stock Set To Rise More? Read More »